1 Min Read
March 12 (Reuters) - Astrazeneca Plc:
* FINAL ANALYSIS OF OVERALL SURVIVAL (OS) IS NOW EXPECTED IN SECOND HALF OF 2018 (PREVIOUSLY ANTICIPATED IN FIRST HALF) Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.